Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Lactobacillus kefiranofaciens was reported to produce an exopolysaccharide named kefiran. In the present study, we developed a new medium, rice hydrolyzate (RH) medium, for the culture of L. kefiranofaciens. Structural analyses revealed that the exopolysaccharide produced by L. kefiranofaciens from RH medium was composed of a hexasaccharide repeating unit, and essentially identical to the kefiran reported in previous studies. A study on the effects of kefiran in animals demonstrated that kefiran significantly suppressed increase of blood pressure and reduced the serum cholesterol levels in SHRSP/Hos rats when subjects consumed excessive dietary cholesterol. Kefiran supplementation demonstrated the ability to significantly lower blood glucose in KKAy mice. In addition, the administration of kefiran in constipated SD rats caused an obvious improvement in the levels of fecal moisture and wet weights of feces. These results suggest that kefiran could be used as a functional food to prevent some commonly occurring diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animals that consumed hyperlipidaemic diets associated with kefiran showed a reduction in serum total cholesterol, LDL-cholesterol and TAG concentrations, as well as a reduction in liver cholesterol and TAG concentrations compared with controls (12) .”
From Milk kefir : nutritional, microbiological and health benefits (2017) · cites this paper as [12]
In the citing paper
“In addition, a study showed that kefiran increased stool weight and moisture in rats, in a dose-responsive manner, compared to control, suggesting a potential beneficial effect in constipation [54].”
From Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease (2019) · cites this paper as [54]
In the citing paper
“suggesting a potential beneficial effect in constipation [54].”
From Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease (2019) · cites this paper as [54]
Citations
Cites
ANTITUMOR ACTIVITY IN MICE OF ORALLY ADMINISTERED POLYSACCHARIDE FROM KEFIR GRAIN
SHIOMI, M., SASAKI, K., MUROFUSHI, M., & AIBARA, K. (1982) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.35.75 · Cited by 124
Lactobacillus kefiranofaciens sp. nov. Isolated from Kefir Grains
FUJISAWA, T., ADACHI, S., TOBA, T., ARIHARA, K., & MITSUOKA, T. (1988) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-38-1-12 · Cited by 88
MUROFUSHI, M., SHIOMI, M., & AIBARA, K. (1983) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.36.49 · Cited by 62
Immunopotentiative effect of polysaccharide from Kefir grain, KGF-C, administered orally in mice
Murofushi, M., Mizuguchi, J., AIBARA, K., & Matuhasi, T. (1986) · Immunopharmacology · doi:10.1016/0162-3109(86)90049-4 · Cited by 56
Structural investigation of the capsular polysaccharide from Lactobacillus kefiranofaciens K1
Mukai, T., Toba, T., Itoh, T., & Adachi, S. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84039-w · Cited by 45
New Medium for the Production of Exopolysaccharide (OSKC) by Lactobacillus kefiranofaciens
Maeda, H., Zhu, X., & MITSUOKA, T. (2003) · Bioscience and Microflora · doi:10.12938/bifidus1996.22.45 · Cited by 13
Self-citation
Cited by
Dimidi, E., Cox, S., Rossi, M., & Whelan, K. (2019) · Nutrients · doi:10.3390/nu11081806 · Cited by 801
“In addition, a study showed that kefiran increased stool weight and moisture in rats, in a dose-responsive manner, compared to control, suggesting a potential beneficial e ff ect in constipation [54].”
BackgroundPostbiotics—A Step Beyond Pre- and Probiotics
Żółkiewicz, J., Marzec, A., Ruszczyński, M., & Feleszko, W. (2020) · Nutrients · doi:10.3390/nu12082189 · Cited by 784
New Perspectives for Lactobacilli Exopolysaccharides
Badel, S., Bernardi, T., & Michaud, P. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.08.011 · Cited by 497
Milk kefir : nutritional, microbiological and health benefits
Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000275 · Cited by 463
“in liver cholesterol and TAG concentrations compared with controls((12)).”
BackgroundThe Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
Bourrie, B. C. T., Willing, B. P., & Cotter, P. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00647 · Cited by 438
Metadata
- Authors
- Maeda, H., Zhu, X., Omura, K., Suzuki, S., & Kitamura, S.
- Affiliations
- Daiwa Pharmaceutical Co. (Japan) (JP)
- Dokkyo University (JP)
- Osaka Prefecture University (JP)
- Corresponding author
- Maeda, Hiroaki
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 22
- Issue
- 1-4
- Pages
- 197-200
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W2042459860
- Cited by
- 167
- References
- 6
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 22 · 2020: 17 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 13 · 2015: 10 · 2014: 13 · 2013: 3 · 2012: 7
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- BioFactors (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- kefiran, exopolysaccharides, Lactobacillus kefiranofaciens, hexasaccharide repeating unit, serum cholesterol, blood pressure, dietary cholesterol, blood glucose, constipation, functional foods, gut microbiota
- MeSH terms
- Animals, Blood Glucose, Blood Pressure, Edible Grain, Cholesterol, Lactobacillus, Lipids, Lipoproteins, Liver, Polysaccharides, Rats, Inbred SHR, Rats, Sprague-Dawley, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.